Ischemic stroke and reperfusion therapies in diabetic patients
- 11 February 2022
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (7) , 4335-4348
Abstract
Introduction The study aimed to identify the main prognostic factors in diabetic patients with ischemic stroke undergoing reperfusion therapies (RT). Methods This retrospective study included 170 diabetic patients: 62 treated with intravenous thrombolysis (IVT) alone and 108 with mechanical thrombectomy (MT). Among MT patients, 29 underwent IVT. We collected clinical, laboratory, and radiological data. The outcomes were 3-month functional impairment (measured by modified Rankin scale, mRs), discharge neurological severity (measured by National Institutes of Health Stroke Scale score, NIHSS), 3-month mortality, intracranial hemorrhage (ICH), and symptomatic intracranial hemorrhage (SICH). We performed a general analysis for all RT and sub-group analyses for IVT and MT. Results A lower mRs was associated with lower glycemia and admission NIHSS (aNIHSS) in all RT and MT; lower aNIHSS and younger age in IVT. Mortality increased with hyperglycemia, aNIHSS, and age in all RT; age and aNIHSS in IVT; hyperglycemia and systolic pressure in MT. A lower discharge NIHSS was related with lower aNIHSS, thrombolysis, and no thrombectomy in all RT; lower aNIHSS in IVT; lower aNIHSS and thrombolysis in MT. ICH was associated with elevated aNIHSS, older age, and lower platelets in all RT; lower platelets and older age in IVT; higher aNIHSS in MT. SICH depended on longer thrombectomy duration in all RT; no metformin use in IVT; higher weight in MT. Conclusion The study shed light on diabetic patients and stroke RT highlighting the protective effect of metformin in IVT and the role of glycemia, weight, and combined treatment in MT.Keywords
This publication has 37 references indexed in Scilit:
- Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental strokeEuropean Journal of Neuroscience, 2014
- Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke ThrombolysisStroke, 2013
- Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic strokeJournal of Neurosurgery, 2011
- Sulfonylurea Use Before Stroke Does Not Influence OutcomeStroke, 2011
- Effects of Metformin in Experimental StrokeStroke, 2010
- RETRACTED: The importance of regulation of blood glucose levels through activation of peripheral 5′-AMP-activated protein kinase on ischemic neuronal damageBrain Research, 2010
- Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous ThrombolysisDiabetes Care, 2008
- Diabetic Autonomic NeuropathyDiabetes Care, 2003
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993